
Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Дек. 17, 2024
Язык: Английский
Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Дек. 17, 2024
Язык: Английский
Frontiers in Immunology, Год журнала: 2025, Номер 16
Опубликована: Фев. 25, 2025
Ovarian cancer (OC) is a severe malignant tumor with significant threat to women's health, characterized by high mortality rate and poor prognosis despite conventional treatments such as cytoreductive surgery platinum-based chemotherapy. Cuproptosis, novel form of cell death triggered copper ion accumulation, has shown potential in therapy, particularly through the involvement CuLncs. This study aims identify risk signatures associated CuLncs OC, construct prognostic model, explore therapeutic drugs impact on OC behavior. We analyzed ovarian data (TCGA-OV) from TCGA database, including transcriptomic clinical 376 patients. Using Pearson correlation LASSO regression, we identified 8 signature model. Patients were categorized into high- low-risk groups based their scores. performed survival analysis, model validation, drug sensitivity vitro experiments assess model's performance functional key proliferation, invasion, migration. The demonstrated predictive power, an area under curve (AUC) 0.702 for 1-year, 0.640 3-year, 0.618 5-year survival, outperforming pathological features stage grade. High-risk patients exhibited higher Tumor Immune Dysfunction Exclusion (TIDE) scores, indicating stronger immune evasion ability. Drugs JQ12, PD-0325901, sorafenib showed reduced IC50 values high-risk group, suggesting benefits. In revealed that knockdown LINC01956, CuLnc signature, significantly inhibited migration cells (P<0.05). Our explored targets OC. findings highlight importance response, providing new insights future research applications.
Язык: Английский
Процитировано
0Frontiers in Cell and Developmental Biology, Год журнала: 2025, Номер 13
Опубликована: Апрель 10, 2025
Colon adenocarcinoma (COAD) remains a major global health challenge with poor prognosis despite advances in treatment, underscoring the need for new biomarkers. As novel mode of cell death, cuproptosis is thought to be potentially involved development cancer. However, particularly as role cuproptosis-related genes (CRGs) COAD and therapy unclear. We analyzed RNA sequencing data from The Cancer Genome Atlas COAD, focusing on CRG expression patterns their clinicopathological correlations. Using Weighted Gene Co-expression Network Analysis (WGCNA) method, we identified gene module most strongly linked conducted functional enrichment analysis explore roles within this tumorigenesis. A prognostic risk model based four CRGs (ORC1, PTTG1, DLAT, PDHB) was developed stratify patients into high-risk low-risk groups, assessing overall survival, tumor microenvironment, mutational landscape differences. also evaluated therapeutic effects ferredoxin 1 (FDX1) elesclomol promoting HCT116 LoVo lines through various experiments, including proliferation, apoptosis assessment, mitochondrial membrane potential evaluation, DLAT lipoylation detection via Western blot. Certain showed different expressions versus normal tissues. WGCNA cuproptosis, crucial pathways like cycle regulation, citrate (TCA cycle), DNA replication. stratified high groups scores, revealing that had shorter survival distinct immune infiltration, while were more sensitive immunotherapy. Experimental results indicated FDX1 exerted an inhibitory effect its combination significantly reduced promoted apoptosis, increased lipoylation, lowered cells. findings study provided perspective research biomarkers strategies value patients, laid theoretical foundation future clinical application CRGs.
Язык: Английский
Процитировано
0Clinical and Translational Medicine, Год журнала: 2024, Номер 14(11)
Опубликована: Ноя. 1, 2024
Язык: Английский
Процитировано
3Biomarker Research, Год журнала: 2024, Номер 12(1)
Опубликована: Окт. 31, 2024
Copper is an important trace element for maintaining key biological functions such as cellular respiration, nerve conduction, and antioxidant defense. Maintaining copper homeostasis critical human health, its imbalance has been linked to various diseases, especially cancer. Cuproptosis, a novel mechanism of copper-induced cell death, provides new therapeutic opportunities metal ion regulation interact with fate. This review insights into the complex mechanisms metabolism, molecular basis cuproptosis, association cancer development. We assess role cuproptosis-related genes (CRGs) associated tumorigenesis, their importance prognostic indicators targets, impact on tumor microenvironment (TME) immune response. Ultimately, this highlights interplay between copper, immunotherapy.
Язык: Английский
Процитировано
2Cancer Pathogenesis and Therapy, Год журнала: 2024, Номер unknown
Опубликована: Июль 1, 2024
Copper (Cu) is an indispensable micronutrient that maintains signaling pathways and biological homeostasis in almost all cell types; however, its excess affects the tricarboxylic acid cycle, causes accumulation of fatty acylated proteins, destabilization iron–sulfur cluster increases levels intracellular reactive oxygen species, leading to proteotoxic stress death. Cuproptosis, a form Cu-dependent death, differs from other types regulated death (RCD) was first reported Science 2022. Recently, RCD have been targeted cancer therapy. However, escape apoptosis tumor cells resistance treatment recurrence. Therefore, there urgent need study alternative mechanisms mortality. Compared normal patients, significant increase serum Cu ion has observed patients with tumors. Moreover, proliferation, angiogenesis, metastasis are associated cuproptosis. Thus, exploring related cuproptosis will provide new perspective for development anti-cancer drugs. Importantly, closely modulation anti-tumor immunity. The expression cuproptosis-related genes (CRGs) significantly correlated immune infiltration checkpoint programmed protein 1 (PD-1)/programmed death-ligand (PD-L1). Based on these findings, series drugs used tumor-targeted combination therapy or as synergists. elucidating role per stage microenvironment (TIME) helpful clarifying potential value specific cancers. In this review, we summarize based regulation concentration. two approaches may help researchers develop more therapies targeting pathways. focused effect TIME systematically discussed CRGs immunity considering CRG-related pathways, prognosis scoring system, immunotherapy, experiments bioinformatics prediction models, ideas anticancer
Язык: Английский
Процитировано
0Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Дек. 17, 2024
Язык: Английский
Процитировано
0